Curriculum Studiorum of Erich Cosmi
Born in Rome, Italy on 1st December 1973
Training and working experience:
1999 Medical Degree with summa con laudeat the University of Rome, "La Sapienza".
1994-1998 visiting scholar at Yale University School of Medicine for 3 consecutive summer years (1994-1996-1998), in which he worked in the Laboratory of Sperm Physiology.
2000 Medical License with 110/100 summa con laude.
2001 Assistant Professor of Obstetrics and Gynecology at the University of Sassari.2001-2003 PhD in maternal and Fetal Medicine atVirginia University Health System.
2001-2003 Assistant Professor in Obstetrics and GynecologyatVirginia University Health System.
2004 Degree of Obstetric and Gynecology residency with Summa con Laude at University ofSassari.
2004 Assistant professor of Obstetrics and Gynecology at University of Padua School of Medicine.
2014 Associate professor of Obstetrics and Gynecology at University of Padua School of Medicine.

He coordinated the research group on growth restriction with Dr. Amhet Baschat involving more than 20 centers in Europe and the United States of America for the management of pregnancies complicated by growth restriction.
Since 2006, directs the research group on cardiovascular risk fetuses and infants with growth restriction, intrauterine diagnosis and integrating the follow-up and pediatric cardiology completing this research with studies and Metabolomics Laboratory Medicine involving the study of genetic collaboration with the Department or Biology, Engineering and Molecular Medicine of the 'University of Padua and the laboratory for DNA analysis at Wayne State University, USA.
It also coordinates the study of pregnancies complicated by cytomegalovirus infection in collaboration with the Department of Infectious Diseases University Padua.

This section will be updated soon...!

Urological Research

Jong Hoon Park is the Director of Research Institute of Women’s Health at Sookmyung Women’s University. He received PhD in Yonsei University in 1996. After two years of postdoctoral work in Molecular Medicine at Albert Einstein College of Medicine, he returned to Korea and joined the faculty of Biological Science Division at Sookmyung Women’s University in 2001. He had worked as a Division Director, Division of Biological Science at NRF, a Review Board member, Division of Biotechnology at NRF and an Advisory Board member at IRB and KNIH in Korea. Also he has worked as Senior Research Scientist at KRIBB in Korea from 1989 to 2001. He is the director of National Research Laboratory for molecular medicine supported by Korean Science and Engineering Foundation program funded by MSIP. His laboratory has been investigating the functional role of pkd2 in ADPKD as well as LY-6k gene in breast cancer. More recently, his laboratory has conducted research evaluating the mechanisms of breast cancer metastasis using flies as a research model and has extended its research into mammalian systems. His laboratory has also set up the technology to scan genome-wide epigenetic modifications such as DNA methylation and histone modification using mouse cancer models. Also, he is currently organizer of A3 foresight program: miRNA analysis. Taken together, his laboratory is very competent in the analysis of novel knock-out mice, their metastatic phenotypes, sampling and analysis of cancer tissue, and monitoring epigenetic modifications.

His laboratory has conducted research evaluating the mechanisms of breast cancer metastasis using flies as a research model and has extended its research into mammalian systems. His laboratory has also set up the technology to scan genome-wide epigenetic modifications such as DNA methylation and histone modification using mouse cancer models.

I am a CKD researcher at Research Center for Health, Work and Environment. Also, Senior lecture at the Department of Public Health at the National Autonomous University of Nicaragua, at León. As well as, Research assistant at the Department of Noncommunicable Disease Epidemiology of London School of Hygiene and Tropical Medicine, London, UK. I received my undergraduate degree in Medicine and surgery in 2007 from the National Autonomous University of Nicaragua at León, and my Msc degree in epidemiology in 2009 from Research Center on Demographic and Health, at National Autonomous University of Nicaragua at León.
I completed master in science on occupational health at the Research Center for Health, Work and Environmental, at National Autonomous University of Nicaragua at León. I joined at the Research Center for Health, Work and Environmental in 2007 as a CKD research assistant, and in 2011 moved to Health Minister, SILAIS Jinotega where I was the health project coordinator and manager of integral attendance of women, child and teenager. In September 2012 he joined to the Research Center for Health, Work and Environmental as the CKD researcher and research assistant of GeoHealth hub for agriculture and informal work in Nicaragua. In 2014 I became as senior lecture of the department of public health at the Faculty of Medicine at UNAN-León.
I have published many articles in the recent years and presented posters in different international congress. I have been a member of SALTRA since 2007, Member of International Commission on Occupational Health since 2013 and Member of ISN in 2015. Also, I am a founding member of CENCAM. Based on these experiences, I am now involved as a member of the Organizing Committee of the MeN2015 workshop.
I currently am studying my PhD at the Department of Non-communicable Disease Epidemiology of London School of Hygiene and Tropical Medicine, London. My research interests are chronic kidney failure, nephrotoxicity, clinical nephrology, kidney disease, Mesoamerican Nephropathy, repetitive episode of dehydration, heat stress, and others. I am currently conducting research on Mesoamerican Nephropathy in Nicaragua, as well as regarding biopsies and dialysis.

My research interests are chronic kidney failure, nephrotoxicity, clinical nephrology, kidney disease, Mesoamerican Nephropathy, repetitive episode of dehydration, heat stress, and others. I am currently conducting research on Mesoamerican Nephropathy in Nicaragua, as well as regarding biopsies and dialysis.

I am young scientist in the field of protein biochemistry and developmental biology. My current research focuses on the role of extracellular vesicles as inductive signals in kidney development. I did my PhD at the Technical University Berlin, in Germany graduating with summa cum laude. The focus of my dissertation work was on protein engineering and enzyme design. Furthermore, I functioned as a group leader in Biocatalysis before I joined the University of Oulu Biocenter and the Center for Cell Matrix Research in Oulu, Finland, in 2014. I also work on promoting open-source software to make it available especially for academic research. And as a young female scientist I am very interested in promoting and enabling women in science. I currently work closely with foundations in Nigeria to help teenage girls obtain education.

My current research focuses on the role of extracellular vesicles as inductive signals in kidney development.

Dr. Grobe obtained her Master’s and doctoral degrees (summa cum laude) in biochemistry from the Martin-Luther-University, Halle-Wittenberg, Germany. During her Ph.D., she worked four years as research scholar at the Donald Danforth Plant Science Center in St. Louis, MO. In 2010, she started a postdoctoral fellowship at the Department of Pharmacology and Toxicology at Wright State University in Dayton, OH, where she was promoted to research faculty in 2013. She has been funded by an American Heart Association fellowship, a NIDDK/NIH Ruth L. Kirschstein NRSA and is the 2015 recipient of the ASN Carl W. Gottschalk Research Scholar Award. Dr. Grobe is currently a scientist at the Air Force Research Laboratory at Wright-Patterson Air Force Base with the Henry M Jackson Foundation for the Advancement of Military Medicine. Dr. Grobe has published in many peer-reviewed journal papers and presented her findings at many national and international conferences.

Dr. Grobeis interested in high-throughput system analyses using genomic, metabolomic and proteomic approaches. Recent projects involve the use of integrative methods, in vitro and in vivo models to examine the mechanisms by which local peptide hormones are formed and regulate physiological processes in the kidney to identify new biomarkers that are capable of detecting pathological changes at its early stages.

This section will be Updated Soon...!

My research Keywords: AKI, Poisoning, Metabolomics in kidney disease

Dr. Taeg Kyu Kwon is a professor of Department Immunology, School of Medicine, Keimyung University in Korea. He received Ph.D. from Kyungpook National University in 1992 and completed his postdoctoral fellowship at the National Institutes of Heath (USA) and Johns Hopkins University (1992-1999).

Mechanisms of cell signaling pathway of cell death
Cancer Biology
Mechanisms of anti-cancer effect of cancer chemopreventive agents

"I惴 Pharmacist by Federal University Of Rio Grande do Norte, Brazil and my concentration area of doctorate is microbiology and mycology, where we develop research with fungal infection of bloodstream and oral cavity, with focusing in identification, characterization of virulence factors, molecular sequencing and taxonomy of clinical isolates, analysis of differentially expressed proteins, using MALDI-TOF technique. We also work with isolation, and characterization of environmental fungus, with emphasis in antifungal resistance and osmotic stress. Using natural products from different products of extractions methods, it愀 evaluated the antifungal activity by inhibition of fungal growth and comparison with synthetic antifungal drugs."

Research with fungal infection of bloodstream and oral cavity, with focusing in identification, characterization of virulence factors, molecular sequencing and taxonomy of clinical isolates, analysis of differentially expressed proteins, using MALDI-TOF technique. We also work with isolation, and characterization of environmental fungus, with emphasis in antifungal resistance and osmotic stress. Using natural products from different products of extractions methods, it愀 evaluated the antifungal activity by inhibition of fungal growth and comparison with synthetic antifungal drugs."

Yoshihide Ogawa, M.D., Ph.D.
Emeritus Professor, Faculty of Medicine, University of the Ryukyus
Lecturer, Center for Kampo Medicine, Keio University School of Medicine
Lecturer, Babel University
Consultant and Chief, Kidney Disease Center, Tokyo-West Tokushukai Hospital
Chief, Department of Urology, Musashino Tokushukai Hospital
Date of Birth: September 18, 1942
Citizenship: Japan

Education:
1968 Clerkship at Neurologische Klinik of Tubingen University in West Germany
1969 Extern, Yokosuka, Tachikawa, Zama US Hospitals
1970 US ECFMG (Register No. 128 585 7)
1970 Graduation from School of Medicine, Keio University
1970 M.D. (Japan Board of Medical Examiners: No. 206134)
1976-1978 Clinical Fellowship in Transplant Surgery, MCV
1978 Virginia Board of Medicine and Surgery (No. 29174)
1982 Ph.D. (Keio University: No. 1287)

Professional Experience:
1970-1971 Assistant of Pediatrics, School of Medicine, Keio University
1971-1976 Assistant of Urology, School of Medicine, Keio University
1976-1978 Clinical Fellow in Transplant Surgery at Medical College of Virginia
1978 M.D. (Virginia State Board of Medicine: No. 29174)
1978-1982 Assistant Professor of Urology, School of Medicine, University of Tsukuba
1982-1994 Associate Professor of Urology, School of Medicine, Juntendo University
1994-1995 Associate Professor of Urology, Faculty of Medicine, University of the Ryukyus
1995-2009 Professor and Chairman, Department of Urology, Faculty of Medicine, University of the Ryukyus Chief of Blood Purification Center, University of the Ryukyus' Hospital
1998-1998 Visiting Professor, Mayo Clinic and Iowa University
2008-Present Emeritus Professor, University of the Ryukyus
2008-Present Consultant, Tokyo-West Tokushukai Hospital
2009-Present Lecturer, Babel University
2010-Present Lecturer, Center for Kampo Medicine, Keio University School of Medicine
2015-Pesent Urology Chief, Musashino Tokushukai Hospital

1) Urolithiasis
2) Kidney transplantation
3) Urology general
4) Pediatric urology
5) Dialysis and vascular access

This section will be updated soon...!

1. Genetic Basis of Mental Disorders
2. Neuroimaging
3. Psychopharmacology
4. Neuroscience
5. Sleep Disorders

Dr. Mustafa Erboga spesialist in Histology and Embryology and working at Department of Histology and Embryology, Namik Kemal University, Faculty of Medicine. He is a longstanding member of the International Federation of Societies of Microscopy, European Microscopy Society, International Federation of Societies for Histochemistry and Cytochemistry, Turkish Society for Electron Microscopy, and Turkish Society of Histology and Embryology. Fields of research prevalent: urological research, urinary tract, experimental studies, reproductive biology, and apoptosis. Author of more than 45 original papers, mainly on gastroenterology and reproductive biology. H-index: 13; number of citations: 369.

Urological research, Urinary tract, Experimental studies, Reproductive biology, and Apoptosis

This section will be updated soon...!

AKI, CKD, Hemodialysis, Diabetic Nephropathy

Wei Phin was born and raised in Kuala Lumpur, Malaysia. He subsequently completed college at Concord College, UK. He completed his medical education at Jefferson Medical College in Philadelphia, where he graduated top third in his class. He was also a recipient of the Hyman Menduke Research Prize and runner up for the Philip J Ripepi Prize in Surgery.
Dr. Tan now pursues his residency in urology at Rush University Medical Center in Chicago, where he currently resides. He has co-authored over 3 book chapters, 15 publications and 40 abstracts to date. He also has given more than 30 oral and poster presentations to date.He also played a key role in the Asian Men’s Health Report which was published in 2013. He has experience as a research coordinator and manager for 6 different databases and was involved in a randomized community based research involving 1760 respondents. He has also served as a research mentor to over 5 medical students to date.
Dr. Tan is also currently a member of the Société Internationaled'Urologie, the American Urological Association, Society of Endourology and the International Society of Men’s Health. He was also a founding member of the American Society of Men’s Health.

Urology
Kidney

This section will be updated soon..!

Research for Renal Physiology and Vascular Pharmacology by Oriental Herbs
1. Oriental Medicines/Vascular Pharmacology/Atherosclerosis/Therapeutics
2. Oriental Medicines/Therapeutics/Diabetic nephropathy
3. Oriental Medicines/Renal injury/Autoregulation/Water channels
4. Oriental Medicines/Cardiac Function and Dynamics: beating rabbit atria

I have graduated from University of Silesia in Poland and started my PhD in 2006 at the University of Liverpool, UK. My PhD project was focused on investigating the potential of mouse embryonic stem cells for generating renal-specific cell types. After defending my thesis in 2010 I began an Alder Hey Children’s Fund Fellowship, also at the University of Liverpool, during which I have established an Adriamycin-induced nephropathy model in mice, in order to investigate the role of various stem cell types in ameliorating kidney diseases. In 2013 I took FiDiPro Postdoctoral Researcher position at the University of Oulu, Finland to investigate the mechanisms of metanephric mesenchyme competence.

I am interested in developmental biology as much as in cellular biology. I am also interested in the mechanisms that are behind structural organization of the organs, especially the kidneys; the ways of organs regeneration on cellular but also physiological levels.

This section will be updated soon...!

1. Endothelial cell function and signal transduction under normal and pathophysiological conditions .
2. Novel pharmacological approaches to improve endothelial function in cardiovascular disease .
3. Gasotransmitters (nitric oxide, hydrogen sulphide) in physiological and pathophysiological conditions (hypertension, diabetes).

2015 Director of Urological, Biomedical and Translational Sciences Department. People's University Nicolaus Copernicus , Cassino (RM) ,Italy
2014 M.D , PhD. People's University Nicolaus Copernicus , Cassino (RM) ,Italy
2014 PhD Degree in Clinical and Experimental Medicine and Surgery (CEMS), School of Advanced Studies , Department of Medicine and Aging, University “G. D’Annunzio” Chieti-Pescara.
Doctoral Thesis : Metabolic Alterations and Vascular Damage in Prostate Cancer.
2012 AWARD-PIERRE FABRE-CIFU, Italian Society of Urology.
2012 Project Planning Course , G. D’Annunzio University of Chieti-Pescara, School of Advanced Studies.
2012 Advanced English Course For Special Purposes. G. D’annunzio University. School of Advanced Studies.
2012 Course Of Scientific English "Writing Across Science”, G. D’annunzio University, School of Advanced Studies, Nazareth College.
2011 Course Scientific English - Uda-Learning , G. D’Annunzio University of Chieti-Pescara.
2010 Specialization in Urology, G. D’Annunzio University of Chieti-Pescara, with maximum marks cum laude.
2009 Specialization in Internist Echography, G. D’Annunzio University of Chieti-Pescara.
2004 Urostage: Kidney , Prostate, Urinary Bladder. University “G. D’Annunzio” Chieti-Pescara, Department of Medicine and Aging, Section of Urology.
2001 XIV International Course of Digestive and Endocrine Surgery. University “G. D’Annunzio” Chieti-Pescara, School of Medicine and Surgery, Italy.
2001-2002 M.D, G.D’Annunzio University of Chieti-Pescara, Medicine and Surgery.

Areas of expertise in Oncology
- Uro-oncology
- Metabolism and prostate cancer
• Obesity and prostate cancer
• Glucose Metabolism and prostate cancer.
• Lipid metabolism and prostate cancer
• Bone metabolism and prostate cancer
• Metabolic alterations and vascular disease in prostate cancer
- Inflammation and prostate cancer

I did my PhD in Experimental Medicine at the University of Messina, Messina, Italy. The main focus of my PhD research was the role of Toll like receptor 4 in inflammatory/immune processes. During my PhD research work, I have also worked with a hydrogen sulfide releasing cyclooxygenase inhibitor that has been tested as a novel non-steroidal anti-inflammatory drug for the experimental therapy of acute inflammation. Shortly after my Ph.D. In 2014, I have joined University of Texas Medical Branch, Galveston, Texas, USA.

Currently, I am doing evaluation of the role of hydrogen sulfide in critically ill conditions, including burn, shock, sepsis and Kidney ischemia. Treatment with H2S donors – in a cecal ligation & puncture induced organ injury model, protects against multiple organ failure, and reduces the plasma levels of multiple pro-inflammatory mediators. Additional studies evaluated the therapeutic effect of a mitochondrially targeted H2S donor compound in a renal ischemia-reperfusion model. These findings, when taken together, support the idea that H2S donors have therapeutic potential in various forms of critical illness. I also participated in studies testing the changes in H2S homeostasis in hyperglycemia; these studies demonstrated that an impairment of the 3-MST/H2S pathway contributes to the pathogenesis of hyperglycemic endothelial cell dysfunction. Further studies showed that therapy with H2S donors, or treatment with the combination of 3-MP and lipoic acid is beneficial in improving angiogenesis and bioenergetics in hyperglycemia.

The role of Toll like receptor 4 in inflammatory/immune processes.

Currently, I am doing evaluation of the role of hydrogen sulfide in critically ill conditions, including burn, shock, sepsis and Kidney ischemia. Treatment with H2S donors – in a cecal ligation & puncture induced organ injury model, protects against multiple organ failure, and reduces the plasma levels of multiple pro-inflammatory mediators. Additional studies evaluated the therapeutic effect of a mitochondrially targeted H2S donor compound in a renal ischemia-reperfusion model. These findings, when taken together, support the idea that H2S donors have therapeutic potential in various forms of critical illness. I also participated in studies testing the changes in H2S homeostasis in hyperglycemia; these studies demonstrated that an impairment of the 3-MST/H2S pathway contributes to the pathogenesis of hyperglycemic endothelial cell dysfunction. Further studies showed that therapy with H2S donors, or treatment with the combination of 3-MP and lipoic acid is beneficial in improving angiogenesis and bioenergetics in hyperglycemia.